Severe neurological complications in an infant during vitamin B12 deficiency treatment: a case report

Disorders of vitamin B (cobalamin) metabolism in children can be manifested by numerous symptoms. They result from the dysfunction of many systems, including the central nervous system. The most common cause of cobalamin deficiency in infants is inadequate supplementation of the vitamin with food. T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pomeranian Journal of Life Sciences 2023-03, Vol.69 (1), p.53-57
Hauptverfasser: Leśniak, Alicja, Patalan, Michał, Sieńko, Magdalena, Stecewicz, Iwona, Walczak, Mieczysław, Giżewska, Maria
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disorders of vitamin B (cobalamin) metabolism in children can be manifested by numerous symptoms. They result from the dysfunction of many systems, including the central nervous system. The most common cause of cobalamin deficiency in infants is inadequate supplementation of the vitamin with food. This mainly affects children who are exclusively breastfed by mothers who follow a diet with insufficient supplementation of vitamin B , including an imbalanced vegetarian or vegan diet. Adequate vitamin B supplementation is essential for the proper growth and development of a child. However, attempts to compensate for severe vitamin B deficiency can paradoxically lead to severe adverse reactions to vitamin B treatment. In this paper, we present a case of a 10-month-old boy with global developmental delay, muscle hypotonia, and profound vitamin B12 deficiency with megaloblastic anemia. The boy developed pathological neurological signs after intramuscular injections of vitamin B . The symptoms included muscle tremors of the upper extremities, head, tongue, and lips. A broad differential diagnosis including inborn errors of metabolism and other genetic disorders is discussed. We describe treatment that led to the complete resolution of symptoms related to the side effects of the B therapy. The patient’s psychomotor development during over 1 year of clinical follow-up is also analyzed.
ISSN:2450-4637
2719-6313
DOI:10.21164/pomjlifesci.913